1. Home
  2. YSG vs FTRE Comparison

YSG vs FTRE Comparison

Compare YSG & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YSG

Yatsen Holding Limited

N/A

Current Price

$4.21

Market Cap

889.0M

ML Signal

N/A

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

N/A

Current Price

$16.14

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YSG
FTRE
Founded
2016
1996
Country
China
United States
Employees
N/A
14500
Industry
Package Goods/Cosmetics
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
889.0M
1.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
YSG
FTRE
Price
$4.21
$16.14
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$12.07
AVG Volume (30 Days)
293.5K
1.4M
Earning Date
11-17-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$571,300,568.00
$2,759,900,000.00
Revenue This Year
$28.96
$3.17
Revenue Next Year
$16.57
$0.04
P/E Ratio
N/A
N/A
Revenue Growth
22.59
1.88
52 Week Low
$3.01
$3.97
52 Week High
$11.57
$20.86

Technical Indicators

Market Signals
Indicator
YSG
FTRE
Relative Strength Index (RSI) 28.34 74.31
Support Level $4.15 $15.40
Resistance Level $5.73 $16.42
Average True Range (ATR) 0.41 1.02
MACD -0.11 0.19
Stochastic Oscillator 28.55 83.63

Price Performance

Historical Comparison
YSG
FTRE

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: